Insight into 144 patients with ocular vascular events during VEGF antagonist injections
Ahmad M Mansour1, Maha Shahin2, Peter K Kofoed3, Maurizio B Parodi4, Michel Shami5, Stephen G Schwartz6, Collaborative Anti-VEGF Ocular Vascular Complications GroupDepartment of Ophthalmology, 1American University of Beirut, Beirut, Lebanon, Rafic Hariri University Hospital, Beirut, Lebanon; 2Mansou...
Guardado en:
Autores principales: | Shami M, Parodi MB, Mansour AM, Kofoed PK, Shahin M, Schwartz SG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/19df5b6c95ae4b2abcd64494f3118f93 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration
por: Mariko Yamashita, et al.
Publicado: (2018) -
Acta No. 144
por: Banco Central de Chile
Publicado: (2019) -
Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin AM, et al.
Publicado: (2017) -
Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
por: Wingard JB, et al.
Publicado: (2019) -
Resolución 144(AC.40): Asistencia técnica = Resolution 144(AC.40): Technical assistance
Publicado: (2014)